Ramipril and Losartan Exert a Similar Long-Term Effect upon Markers of Heart Failure, Endogenous Fibrinolysis, and Platelet Aggregation in Survivors of ST-Elevation Myocardial Infarction: A Single Centre Randomized Trial

<div>Baseline characteristics of all STEMI patients and comparison between ramipril and losartan treated STEMI patients. STEMI: ST-elevation myocardial infarction; PPCI: primary percutaneous coronary intervention; ASA: acetylsalicylic acid.</div>

BioMed Research International

fig1

Figure 1

Figure 1: Ramipril and Losartan Exert a Similar Long-Term Effect upon Markers of Heart Failure, Endogenous Fibrinolysis, and Platelet Aggregation in Survivors of ST-Elevation Myocardial Infarction: A Single Centre Randomized Trial 

Figure 1 | Ramipril and Losartan Exert a Similar Long-Term Effect upon Markers of Heart Failure, Endogenous Fibrinolysis, and Platelet Aggregation in Survivors of ST-Elevation Myocardial Infarction: A Single Centre Randomized Trial 